Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New perspectives for research on hepatitis C virus

09.03.2017

The hepatitis C virus (HCV) infects around 160 million people. Although there are new therapies, HCV infection is one of the most common causes of liver transplantation as these new drugs are very expensive and not used extensively.

Also vaccination against HCV is currently impossible. Scientists at the TWINCORE are now investigating a very close relative of the hepatitis C virus: the "non-primate hepacivirus", (NPHV). This newly discovered viral pathogen infects horses and donkeys and raises questions that will give new insights about the human hepatitis C virus. In a recent study, published in PNAS, the researchers have focused on immune control of NPHV in its natural host, the horse.


The "equine nonprimate hepacivirus" (NPHV) induces hepatic membrane rearrangements similar to Hepatitis C Virus.

Ines Romero-Brey

One of the biggest problems in developing new approaches against HCV is the extremely narrow host range of the virus: it infects only humans and chimpanzees. Researchers can investigate HCV biology in cell-culture, but this approach cannot mimic the human immune system. Consequently it has been very difficult to develop and investigate vaccination strategies against HCV.

"NPHV is the most similar virus to HCV that we know of." says Dr. Stephanie Pfänder, former scientist at the TWINCORE, now at the Institute for Virology and Immunology (IVI) in Berne. Like HCV, NPHV is also specialized to its host: horses are the natural host of the virus, in addition to donkeys.

And NPHV multiplies mainly within the liver – something also shared between the two viruses. However, unlike humans, horses do not appear to get sick after infection. They show no symptoms, or in a few cases mild symptoms, and usually their immune system has eliminated the virus after a few weeks.

"In our initial studies on NPHV in 2014, we found antibodies against the virus in a high percentage of the studied thoroughbred horses from a renowned breeding program. This means that many of these horses have already been infected with the virus without that the infection being noticed." says Prof. Eike Steinmann, head of the Virus Transmission group at the Institute of Experimental Virology at TWINCORE. Is the "horse-NPHV" pairing perhaps the long-sought after animal model which can help scientists can develop a vaccine against HCV?

To find out, the TWINCORE scientists Eike Steinmann, Stephanie Pfänder and Stephanie Walter, in close cooperation with the horse clinic, the Institute of Pathology and the Institute of Virology of the Foundation of the University of Veterinary Medicine Hannover infected three horses, which had no antibodies against NPHV, under controlled conditions and collected blood for the analysis of immune cells once a week.

"The immune system had eliminated the virus in one case after only one week and in the other two cases after eight weeks," says Stephanie Pfänder. "As we were unable to observe a strong general immune response, we suspect that the defense response of the immune system has mainly occurred in the liver."

With this knowledge the scientists have asked an important: can a first infection with NPHV help to protect against a second infection? "We infected the horses with the same virus strain five months after they had cleared the infections," explains the co-investigator from the Horses Clinics, PD Dr. Jessika Cavalleri. "The horses were protected by their previous infection.

The first infection thus appears to be a ‘vaccination’." And the horses were also immune against another variant of the virus, as further infections could show some months later. However, the genetic range of NPHV is far from the broad diversity of HCV- all known NPH-viruses are quite similar.

"These results could facilitate the development of vaccines for hepatitis C," says Eike Steinmann. "For the first time, we are able to investigate a very similar virus to the HC virus in its natural host - which is still able to ward off the virus."

Publication:

Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero-Brey I, Gather T, Brown RJP, Hahn K, Puff C, Pfankuche VM, Hansmann F, Postel A, Becher P, Thiel V, Kalinke U, Wagner B, Bartenschlager R, Baumgärtner W, Feige K, Pietschmann T, Cavalleri JM, Steinmann E (2017). Immune protection against re-infection with non-primate hepacivirus. PNAS published ahead of print March 8, 2017, doi:10.1073/pnas.1619380114

Weitere Informationen:

http://www.twincore.de/en/infothek-and-press/infothek-news-single/news/new-persp...

Dr. Jo Schilling | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Flavins keep a handy helper in their pocket
25.04.2018 | University of Freiburg

nachricht Complete skin regeneration system of fish unraveled
24.04.2018 | Tokyo Institute of Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Getting electrons to move in a semiconductor

25.04.2018 | Physics and Astronomy

Reconstructing what makes us tick

25.04.2018 | Physics and Astronomy

Cheap 3-D printer can produce self-folding materials

25.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>